<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="26" left="55" width="517" height="27" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="601" left="238" width="188" height="12" font="1">http://www.scbt.com/datasheet-30189-cores</text>
<text top="613" left="238" width="88" height="12" font="1">t-h-65-antibody.html</text>
<text top="77" left="138" width="27" height="12" font="1">1/4/12</text>
<text top="340" left="95" width="428" height="12" font="1">epitope corresponding to amino acids 246-310 mapping within an internal region of CoREST of human </text>
<text top="352" left="95" width="27" height="12" font="1">origin </text>
<text top="364" left="95" width="295" height="12" font="1">recommended for detection of CoREST of mouse, rat and human origin</text>
<text top="484" left="150" width="31" height="12" font="1">Human</text>
<text top="520" left="178" width="89" height="12" font="2">Immunoprecipitation</text>
<text top="134" left="326" width="92" height="12" font="1">sglandt@stanford.edu</text>
<text top="134" left="83" width="61" height="12" font="1">Stephen Landt</text>
<text top="214" left="121" width="141" height="12" font="1">CoREST (H-65) Antibody: sc-30189</text>
<text top="214" left="339" width="128" height="12" font="1">COREST (EntrezGene ID 23186)</text>
<text top="170" left="230" width="29" height="12" font="1">Snyder</text>
<text top="255" left="239" width="107" height="12" font="1">Santa Cruz Biotechnology</text>
<text top="484" left="361" width="27" height="12" font="1">Rabbit</text>
<text top="300" left="395" width="26" height="12" font="1">C0806</text>
<text top="300" left="215" width="39" height="12" font="1"> sc-30189</text>
<text top="520" left="395" width="19" height="12" font="2">ChIP</text>
<text top="561" left="141" width="109" height="12" font="2">Other Purification Method</text>
<text top="561" left="356" width="43" height="12" font="2">Polyclonal</text>
<text top="412" left="95" width="398" height="12" font="1">Essential component of the BHC complex, a corepressor complex that represses transcription of </text>
<text top="424" left="95" width="67" height="12" font="1">neuron-specific </text>
<text top="436" left="95" width="401" height="12" font="1">genes in non-neuronal cells. The BHC complex is recruited at RE1/NRSE sites by REST and acts by </text>
<text top="448" left="95" width="77" height="12" font="1">deacetylating and </text>
<text top="460" left="95" width="430" height="12" font="1">demethylating specific sites on histones, thereby acting as a chromatin modifier. In the BHC complex, it </text>
<text top="472" left="95" width="46" height="12" font="1">serves as a </text>
<text top="484" left="95" width="451" height="12" font="1">molecular beacon for the recruitment of molecular machinery, including MeCP2 and SUV39H1, that imposes </text>
<text top="496" left="95" width="39" height="12" font="1">silencing </text>
<text top="508" left="95" width="435" height="12" font="1">across a chromosomal interval. Plays a central role in demethylation of Lys-4 of histone H3 by promoting </text>
<text top="521" left="95" width="56" height="12" font="1">demethylase </text>
<text top="533" left="95" width="402" height="12" font="1">activity of KDM1A on core histones and nucleosomal substrates. It also protects KDM1A from the </text>
<text top="545" left="95" width="50" height="12" font="1">proteasome</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="43" left="125" width="411" height="12" font="1">COMMENT:  We observe a single band in Western blots on cell lines K562, HeLa S3, and HepG2 that </text>
<text top="55" left="125" width="403" height="12" font="1">migrates slightly slower than the predicted size (~53kD) would suggest. This has been previously </text>
<text top="67" left="125" width="422" height="12" font="1">observed (see product literature for this and other commercial antibodies, as well as the Western blot </text>
<text top="79" left="125" width="431" height="12" font="1">assays in our characterization document for ab24166 against COREST).  This band, but not the observed </text>
<text top="91" left="125" width="421" height="12" font="1">weaker bands, is specifically immunoprecipitated by sc-30189. Based on this, sc-30189 is validated by </text>
<text top="103" left="125" width="57" height="12" font="1">this criterion. </text>
</page>
<page number="3" position="absolute" top="0" left="0" height="612" width="792">
	<fontspec id="3" size="10" family="Times" color="#000000"/>
	<fontspec id="4" size="10" family="Times" color="#000000"/>
	<fontspec id="5" size="8" family="Times" color="#000000"/>
	<fontspec id="6" size="14" family="Times" color="#000000"/>
	<fontspec id="7" size="16" family="Times" color="#000000"/>
	<fontspec id="8" size="22" family="Times" color="#000000"/>
<text top="337" left="71" width="629" height="13" font="3"><b>A.  </b>Western blot using antibody sc-30189 on nuclear lysates from cell lines GM12878 (Lane1), K562 (Lane2), HeLaS3 </text>
<text top="351" left="71" width="592" height="13" font="4">(Lane3), and HepG2 (Lane4).<b>  B.</b> Immunoprecipitation was performed on nuclear lysates from K562 cells using </text>
<text top="365" left="71" width="628" height="13" font="4">antibody sc-30189.  Lane1: Nuclear lysate.  Lane 2: Unbound material from immunoprecipitation with sc-30189.  Lane </text>
<text top="380" left="71" width="536" height="13" font="4">3: Bound material from immunoprecipitation with sc- sc-30189.  Lane 4:  Bound material from control </text>
<text top="394" left="71" width="594" height="13" font="4">immunoprecipitation with rabbit IgG.  Arrow indicates band of expected size (18kD) that is highly enriched in the </text>
<text top="409" left="71" width="219" height="13" font="4">specifically immunoprecipitated fraction.  </text>
<text top="423" left="71" width="3" height="13" font="4"> </text>
<text top="158" left="222" width="42" height="11" font="1">MW (kD) </text>
<text top="189" left="229" width="19" height="11" font="1">100 </text>
<text top="199" left="229" width="14" height="11" font="1">75 </text>
<text top="216" left="229" width="14" height="11" font="1">50 </text>
<text top="229" left="229" width="14" height="11" font="1">38 </text>
<text top="175" left="229" width="19" height="11" font="1">150 </text>
<text top="245" left="229" width="14" height="11" font="1">25 </text>
<text top="254" left="229" width="14" height="11" font="1">20 </text>
<text top="268" left="229" width="14" height="11" font="1">15 </text>
<text top="289" left="221" width="83" height="11" font="5"><b>Lane: 1  2  3  4 </b></text>
<text top="291" left="467" width="29" height="11" font="5"><b>Lane: </b></text>
<text top="158" left="474" width="42" height="11" font="1">MW (kD) </text>
<text top="189" left="476" width="19" height="11" font="1">100 </text>
<text top="201" left="476" width="14" height="11" font="1">75 </text>
<text top="219" left="476" width="14" height="11" font="1">50 </text>
<text top="233" left="476" width="14" height="11" font="1">38 </text>
<text top="173" left="476" width="19" height="11" font="1">150 </text>
<text top="250" left="476" width="14" height="11" font="1">25 </text>
<text top="291" left="501" width="23" height="11" font="5"><b>1  2 </b></text>
<text top="269" left="476" width="14" height="11" font="1">15 </text>
<text top="291" left="533" width="8" height="11" font="5"><b>3 </b></text>
<text top="291" left="563" width="8" height="11" font="5"><b>4 </b></text>
<text top="159" left="198" width="20" height="18" font="6">A. </text>
<text top="159" left="450" width="22" height="20" font="7">B. </text>
<text top="68" left="227" width="328" height="27" font="8">Antibody sc-30189 (COREST) </text>
<text top="96" left="218" width="347" height="27" font="8">Immunoblot/immunoprecipitation</text>
<text top="107" left="561" width="3" height="13" font="4"> </text>
</page>
<page number="4" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="698" left="268" width="68" height="10" font="1">Submit by Email</text>
<text top="43" left="130" width="393" height="12" font="1">Comment: Because the overlap of the top 40% of peaks from datasets derived from antibodies </text>
<text top="55" left="130" width="369" height="12" font="1">sc30189 and ab24166 (compared using standard ENCODE scoring methods) exceeds the </text>
<text top="67" left="130" width="345" height="12" font="1">recommended threshold of 80%, both antibodies meet this criterion for validation. </text>
</page>
<page number="5" position="absolute" top="0" left="0" height="612" width="792">
	<fontspec id="9" size="10" family="Times" color="#00a8a9"/>
	<fontspec id="10" size="11" family="Times" color="#000000"/>
	<fontspec id="11" size="14" family="Times" color="#e62400"/>
	<fontspec id="12" size="18" family="Times" color="#000000"/>
<text top="306" left="77" width="3" height="13" font="4"> </text>
<text top="320" left="77" width="69" height="13" font="3"><b>Antibodies:</b> </text>
<text top="334" left="77" width="475" height="13" font="3"><b>sc30189:</b> epitope corresponding to amino acids 246-310 within CoREST of human origin </text>
<text top="349" left="77" width="651" height="13" font="3"><b>ab24166:</b> immunogen is synthetic peptide conjugated to KLH derived from resides 400 to C-terminus of human COREST.  </text>
<text top="363" left="77" width="3" height="13" font="4"> </text>
<text top="378" left="77" width="638" height="13" font="3"><b>Comparison</b>: K562 cells were used for ChIP-seq with antibody sc-30189 or antibody ab24166.  Peaks were called from </text>
<text top="392" left="91" width="628" height="13" font="4">replicate experiments using PeakSeq with a .01 q-value cut-off.  Comparisons between experiments were made using </text>
<text top="406" left="91" width="423" height="13" font="4">these peaks according to standard ENCODE replicate comparison parameters (</text>
<text top="421" left="91" width="548" height="13" font="9">http://genome.ucsc.edu/ENCODE/protocols/dataStandards/ChIP_DNase_FAIRE_DNAme_v2_2011.pdf</text>
<text top="421" left="639" width="87" height="13" font="4">; reported is the </text>
<text top="435" left="91" width="604" height="13" font="4">fraction of the  top 40% of peaks in one list that are found in the full list of peaks obtained with the other antibody.  </text>
<text top="191" left="371" width="62" height="16" font="10">COREST </text>
<text top="208" left="374" width="53" height="16" font="10">sc30189</text>
<text top="191" left="446" width="62" height="16" font="10">COREST </text>
<text top="208" left="448" width="54" height="16" font="10">ab24166</text>
<text top="229" left="311" width="35" height="16" font="10">Total </text>
<text top="246" left="307" width="37" height="16" font="10">peaks</text>
<text top="238" left="378" width="46" height="16" font="10">111692</text>
<text top="238" left="455" width="39" height="16" font="10">30269</text>
<text top="264" left="302" width="52" height="16" font="10">% Peak </text>
<text top="281" left="303" width="50" height="16" font="10">overlap </text>
<text top="271" left="385" width="31" height="18" font="11"><b>87.6</b></text>
<text top="271" left="459" width="31" height="18" font="11"><b>93.2</b></text>
<text top="111" left="88" width="621" height="22" font="12"><b>Validation 2: ChIPseq with alternate antibodies to the same factor</b></text>
<text top="108" left="702" width="7" height="27" font="8"> </text>
<text top="136" left="48" width="7" height="27" font="8"> </text>
</page>
</pdf2xml>
